- Corporate Officers - J
- Johnson Craig A
Insider Trading History of Johnson Craig A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Johnson Craig A since 2011.
This trader's CIK number is 1370348.
At the time of last reporting, Johnson Craig A was the Director of La Jolla Pharmaceutical Co. (stock ticker symbol LJPC).
Also see all insider trading activities at La Jolla Pharmaceutical Co.
Note that in the past
Johnson Craig A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at La Jolla Pharmaceutical Co (LJPC) by Johnson Craig A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | LJPC | 0 | $0 | 0 | $0 | 12,000 | $47,160 |
Yearly summary of insider trading at Mirati Therapeutics, Inc. (MRTX) by Johnson Craig A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | MRTX | 0 | $0 | 15,000 | $3,185,250 | 15,000 | $308,100 |
| 2020 | MRTX | 0 | $0 | 15,000 | $1,395,000 | 15,000 | $387,600 |
| 2019 | MRTX | 0 | $0 | 17,000 | $1,044,752 | 17,000 | $165,240 |
Yearly summary of insider trading at Heron Therapeutics, Inc. /de/ (HRTX) by Johnson Craig A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | HRTX | 0 | $0 | 1,000 | $13,611 | 0 | $0 |
Yearly summary of insider trading at Intrabiotics Pharmaceuticals Inc /de (RDEA) by Johnson Craig A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | RDEA | 0 | $0 | 2,000 | $52,732 | 2,000 | $24,320 |
Yearly summary of insider trading at Odonate Therapeutics, Inc. (ODT) by Johnson Craig A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ODT | 3,000 | $51,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Johnson Craig A:
1. La Jolla Pharmaceutical Co (LJPC)
2. Mirati Therapeutics, Inc. (MRTX)
3. Heron Therapeutics, Inc. /de/ (HRTX)
4. Intrabiotics Pharmaceuticals Inc /de (RDEA)
5. Odonate Therapeutics, Inc. (ODT)
Table 1. Insider trading of La Jolla Pharmaceutical Co (LJPC) by Johnson Craig A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-07-08 | LJPC | Option Ex | 12,000 | 3.93 | 47,160 |
Table 2. Insider trading of Mirati Therapeutics, Inc. (MRTX) by Johnson Craig A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-21 | MRTX | Option Ex | 15,000 | 20.54 | 308,100 |
| 2021-01-21 | MRTX | Sale | 15,000 | 212.35 | 3,185,250 |
| 2020-04-20 | MRTX | Option Ex | 15,000 | 25.84 | 387,600 |
| 2020-04-20 | MRTX | Sale | 15,000 | 93.00 | 1,395,000 |
| 2019-01-29 | MRTX | Option Ex | 17,000 | 9.72 | 165,240 |
| 2019-01-29 | MRTX | Sale | 17,000 | 61.46 | 1,044,752 |
Table 3. Insider trading of Heron Therapeutics, Inc. /de/ (HRTX) by Johnson Craig A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-21 | HRTX | Sale | 250 | 9.73 | 2,432 |
| 2021-09-21 | HRTX | Sale | 250 | 12.30 | 3,074 |
| 2021-06-21 | HRTX | Sale | 250 | 15.20 | 3,800 |
| 2021-04-06 | HRTX | Sale | 250 | 17.22 | 4,305 |
Table 4. Insider trading of Intrabiotics Pharmaceuticals Inc /de (RDEA) by Johnson Craig A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-07-01 | RDEA | Option Ex | 2,000 | 12.16 | 24,320 |
| 2011-07-01 | RDEA | Sale | 2,000 | 26.37 | 52,732 |
Table 5. Insider trading of Odonate Therapeutics, Inc. (ODT) by Johnson Craig A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-29 | ODT | Buy | 3,000 | 17.00 | 51,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Johnson Craig A
(Director of La Jolla Pharmaceutical Co at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.